0001628280-26-059671.txt : 20260831 0001628280-26-059671.hdr.sgml : 20260831 20260831192532 ACCESSION NUMBER: 0001628280-26-059671 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20260827 FILED AS OF DATE: 20260831 DATE AS OF CHANGE: 20260831 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Roseth Aaron Robert CENTRAL INDEX KEY: 0002145472 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37815 FILM NUMBER: 261348179 MAIL ADDRESS: STREET 1: AARON ROSETH C/O CHIRON REAL ESTATE INC. STREET 2: 7373 WISCONSIN AVENUE, SUITE 800 CITY: BETHESDA STATE: MD ZIP: 20814 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Chiron Real Estate Inc. CENTRAL INDEX KEY: 0001533615 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] ORGANIZATION NAME: 05 Real Estate & Construction EIN: 464757266 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7373 WISCONSIN AVENUE STREET 2: SUITE 800 CITY: BETHESDA STATE: MD ZIP: 20814 BUSINESS PHONE: 202-524-6851 MAIL ADDRESS: STREET 1: 7373 WISCONSIN AVENUE STREET 2: SUITE 800 CITY: BETHESDA STATE: MD ZIP: 20814 FORMER COMPANY: FORMER CONFORMED NAME: Global Medical REIT Inc. DATE OF NAME CHANGE: 20140207 FORMER COMPANY: FORMER CONFORMED NAME: SCOOP MEDIA, INC. DATE OF NAME CHANGE: 20111027 4 1 wk-form4_1788218730.xml FORM 4 X0609 4 2026-08-27 0 0001533615 Chiron Real Estate Inc. XRN 0002145472 Roseth Aaron Robert false 7373 WISCONSIN AVENUE, SUITE 800 BETHESDA MD 20814 0 1 0 0 COO 0 Option (Right to buy) 60 2026-08-27 4 A 0 23855 0 A 2036-08-27 Common Stock 23855 23855 D The options have an exercise price of $60.00 per share and the shares subject to the options become exercisable in three equal annual installments on each of August 27, 2027, August 27, 2028 and August 27, 2029, subject to the Reporting Person's continued service through each applicable vesting date. The options were granted outside of the Issuer's 2016 Equity Incentive Plan as an employment inducement award under New York Stock Exchange Listing Rule 303A.08 and as a material inducement to the Reporting Person entering into employment with the Issuer. The awards were approved by the Compensation Committee of the Board of Directors, consisting solely of independent directors, in reliance on the employment inducement exemption under NYSE Listing Rule 303A.08. The Reporting Person was inadvertently designated as a director in a previously filed Form 4. The Reporting Person was not a director of the Issuer at the time of such filing. This Form 4 reflects the Reporting Person's correct officer status. /s/ Jamie Barber, as Attorney-in-Fact 2026-08-31